Takahiko Nishiyama, Rhonda Bassel-Duby, and Eric N. Olson
doi : 10.1161/CIRCULATIONAHA.121.057203
Circulation. 2021;144:1525–1527
Seulggie Choi, Kiheon Lee, and Sang Min Park
doi : 10.1161/CIRCULATIONAHA.121.054967
Circulation. 2021;144:1528–1538
The associations of changes in noncombustible nicotine or tobacco product (NNTP) and combustible cigarette (CC) use habits with subsequent cardiovascular disease (CVD) risk are still unclear.
Reto Auer, Pascal Diethelm, and Aurélie Berthet
doi : 10.1161/CIRCULATIONAHA.121.056959
Circulation. 2021;144:1539–1542
Dhanunjaya Lakkireddy, David Thaler, Christopher R. Ellis, Vijendra Swarup, Lars Sondergaard, John Carroll, Michael R. Gold, James Hermiller, Hans-Christoph Diener, Boris Schmidt, Lee MacDonald, Moussa Mansour, Brijeshwar Maini, Laura O’Brien, Stephan Windecker, on behalf of the Amulet IDE Investigators
doi : 10.1161/CIRCULATIONAHA.121.057063
Circulation. 2021;144:1543–1552
Percutaneous closure of the left atrial appendage (LAA) is an alternative to chronic oral anticoagulation to reduce stroke risk in patients with nonvalvular atrial fibrillation. The Amulet IDE trial (Amplatzer Amulet Left Atrial Appendage Occluder IDE Trial) was designed to evaluate the safety and effectiveness of the dual-seal mechanism of the Amulet LAA occluder compared with the Watchman device.
Maria Carmo P. Nunes, Lewis F. Buss, Jose Luiz P. Silva, Larissa Natany A. Martins, Claudia Di Lorenzo Oliveira, Clareci Silva Cardoso, Bruno Oliveira de Figueiredo Brito, Ariela Mota Ferreira, Lea Campos Oliveira, Ana Luiza Bierrenbach, Fabio Fernandes, Michael P. Busch, Viviane Tiemi Hotta, Luiz Mario Baptista Martinelli, Maria Carolina F. Almeida Soeiro, Adriana Brentegani, Vera M.C. Salemi, Marcia M. Menezes, Antonio Luiz P. Ribeiro, and Ester Cerdeira Sabino
doi : 10.1161/CIRCULATIONAHA.121.055112
Circulation. 2021;144:1553–1566
There are few contemporary cohorts of Trypanosoma cruzi–seropositive individuals, and the basic clinical epidemiology of Chagas disease is poorly understood. Herein, we report the incidence of cardiomyopathy and death associated with T. cruzi seropositivity.
Francesca Fasolo, Hong Jin, Greg Winski, Ekaterina Chernogubova, Jessica Pauli, Hanna Winter, Daniel Y. Li, Nadiya Glukha, Sabine Bauer, Susanne Metschl, Zhiyuan Wu, Marlys L. Koschinsky, Muredach Reilly, Jaroslav Pelisek, Wolfgang Kempf, Hans-Henning Eckstein, Oliver Soehnlein, Ljubica Matic, Ulf Hedin, Alexandra Bäcklund, Claes Bergmark, Valentina Paloschi, and Lars Maegdefessel
doi : 10.1161/CIRCULATIONAHA.120.052023
Circulation. 2021;144:1567–1583
Long noncoding RNAs (lncRNAs) are important regulators of biological processes involved in vascular tissue homeostasis and disease development. The present study assessed the functional contribution of the lncRNA myocardial infarction-associated transcript (MIAT) to atherosclerosis and carotid artery disease.
David C. Tong, Jason E. Bloom, Stephen Quinn, Arthur Nasis, Chin Hiew, Philip Roberts-Thomson, Heath Adams, Rumes Sriamareswaran, Nay M. Htun, William Wilson, Dion Stub, William van Gaal, Laurie Howes, Allysha Yeap, Brian Yip, Sam Wu, Padeepa Perera, Nicholas Collins, Andy Yong, Ravinay Bhindi, Robert Whitbourn, Astin Lee, Manuja Premaratne, Kaleab Asrress, Melanie Freeman, John Amerena, and Jamie Layland
doi : 10.1161/CIRCULATIONAHA.121.054610
Circulation. 2021;144:1584–1586
Ibrahim Schaefer, Pedro Lopez-Ayala, and Christian Mueller
doi : 10.1161/CIRCULATIONAHA.121.055719
Circulation. 2021;144:e283–e284
Brandon R. Allen, Robert H. Christenson, Scott A. Cohen, Michael T. Weaver, Kai Yang, and Simon A. Mahler
doi : 10.1161/CIRCULATIONAHA.121.056533
Circulation. 2021;144:e285–e286
Kurt Ruetzler, Nathaniel R. Smilowitz, Jeffrey S. Berger, P.J. Devereaux, Bradley A. Maron, L. Kristin Newby, Vinicio de Jesus Perez, Daniel I. Sessler, Duminda N. Wijeysundera, on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; and Council on Cardiovascular Surgery and Anesthesia
doi : 10.1161/CIR.0000000000001024
Circulation. 2021;144:e287–e305
Myocardial injury after noncardiac surgery is defined by elevated postoperative cardiac troponin concentrations that exceed the 99th percentile of the upper reference limit of the assay and are attributable to a presumed ischemic mechanism, with or without concomitant symptoms or signs. Myocardial injury after noncardiac surgery occurs in ?20% of patients who have major inpatient surgery, and most are asymptomatic. Myocardial injury after noncardiac surgery is independently and strongly associated with both short-term and long-term mortality, even in the absence of clinical symptoms, electrocardiographic changes, or imaging evidence of myocardial ischemia consistent with myocardial infarction. Consequently, surveillance of myocardial injury after noncardiac surgery is warranted in patients at high risk for perioperative cardiovascular complications. This scientific statement provides diagnostic criteria and reviews the epidemiology, pathophysiology, and prognosis of myocardial injury after noncardiac surgery. This scientific statement also presents surveillance strategies and treatment approaches.
doi : 10.1161/CIR.0000000000001034
Circulation. 2021;144:e306
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟